Cancer drug resistance: an evolving paradigm, Nat. Rev. Cancer, vol.13, pp.714-726, 2013. ,
Old drugs, novel ways out: drug resistance toward cytotoxic chemotherapeutics, Drug Resist. Updat, vol.28, pp.65-81, 2016. ,
Context-dependent control of alternative splicing by RNA-binding proteins, Nat. Rev. Genet, vol.15, pp.689-701, 2014. ,
Hallmarks of alternative splicing in cancer, Oncogene, vol.33, pp.5311-5318, 2014. ,
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged, Genes Dev, vol.24, pp.2343-2364, 2010. ,
RNA splicing factors as oncoproteins and tumour suppressors, Nat. Rev. Cancer, vol.16, pp.413-430, 2016. ,
SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition, Cancer Cell, vol.27, pp.617-630, 2015. ,
Mutant U2AF1 expression alters hematopoiesis and pre-mRNA splicing in vivo, Cancer Cell, vol.27, pp.631-643, 2015. ,
Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron, Leukemia, vol.29, pp.188-195, 2015. ,
Splicing factor SF3B1K700E mutant dysregulates erythroid differentiation via aberrant alternative splicing of transcription factor TAL1, PLoS One, vol.12, p.175523, 2017. ,
mRNA splicing variants: exploiting modularity to outwit cancer therapy, Cancer Res, vol.73, pp.5309-5314, 2013. ,
The role of alternative splicing in cancer drug resistance, Curr. Opin. Genet. Dev, vol.48, pp.16-21, 2018. ,
Aberrant RNA splicing in cancer and drug resistance, Cancers (Basel), vol.10, p.458, 2018. ,
Splicing regulation: a molecular device to enhance cancer cell adaptation, Biomed. Res. Int, p.543067, 2015. ,
Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells, Oncogene, vol.35, pp.2031-2039, 2016. ,
TRA2A promoted paclitaxel resistance and tumor progression in triple-negative breast cancers via regulating alternative splicing, Mol. Cancer Ther, vol.16, pp.1377-1388, 2017. ,
Oncogene-and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML), Oncotarget, vol.7, pp.2889-2909, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01812676
Using RNA-sequencing to detect novel splice variants related to drug resistance in in vitro cancer models, J. Vis. Exp, vol.1, p.201800088, 2016. ,
A recently evolved class of alternative 3 -terminal exons involved in cell cycle regulation by topoisomerase inhibitors, Nat. Commun, vol.5, p.3395, 2014. ,
ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance, Mol. Cancer Ther, vol.10, pp.1046-1058, 2011. ,
Silica-based solid-phase extraction of cross-linked nucleic acid-bound proteins, Life Sci. Alliance, vol.1, 2018. ,
rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data, Proc. Natl. Acad. Sci. U.S.A, vol.111, pp.5593-5601, 2014. ,
Complementarity of assembly-first and mapping-first approaches for alternative splicing annotation and differential analysis from RNAseq data, Sci. Rep, vol.8, p.4307, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01924204
) rMAPS: RNA map analysis and plotting server for alternative exon regulation, Nucleic Acids Res, vol.44, pp.333-338, 2016. ,
The RNA-binding protein Rbfox2: An essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion, Oncogene, vol.33, pp.1082-1092, 2014. ,
Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1/?-catenin signaling pathway in breast cancer, Cancer Med, vol.8, pp.1246-1257, 2019. ,
Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells, Clin. Cancer Res, vol.15, pp.2657-2665, 2009. ,
Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells, Endocr. Relat. Cancer, vol.20, pp.1-12, 2013. ,
, , 2013.
, Post-transcriptional drivers of cancer progression?, mRNA-binding proteins (IGF2BPs), vol.70, pp.2657-2675
ZRANB2: structural and functional insights into a novel splicing protein, Int. J. Biochem. Cell Biol, vol.40, pp.2353-2357, 2008. ,
Resources for the comprehensive discovery of functional RNA elements, Mol. Cell, vol.61, pp.903-913, 2016. ,
Splicing and beyond: the many faces of the Prp19 complex, Biochim. Biophys. Acta -Mol. Cell Res, vol.1833, pp.2126-2134, 2013. ,
The zinc fingers of the SR-like protein ZRANB2 are single-stranded RNA-binding domains that recognize 5 splice site-like sequences, Proc. Natl. Acad. Sci. U.S.A, vol.106, pp.5581-5586, 2009. ,
Spatiotemporal regulation of RhoA during cytokinesis, Curr. Biol, vol.28, pp.570-580, 2018. ,
Crystal structure of triple-BRCT-domain of ECT2 and insights into the binding characteristics to CYK-4, FEBS Lett, vol.588, pp.2911-2920, 2014. ,
The nuclear guanine nucleotide exchange factors Ect2 and Net1 regulate RhoB-mediated cell death after DNA damage, PLoS One, vol.6, p.17108, 2011. ,
The dynamic behavior of Ect2 in response to DNA damage, Sci. Rep, vol.6, p.24504, 2016. ,
TrapSeq: An RNA sequencing-based pipeline for the identification of gene-trap insertions in mammalian cells, J. Mol. Biol, vol.429, pp.2780-2789, 2017. ,
Modulation of alternative splicing induced by paclitaxel in human lung cancer, Cell Death Dis, vol.9, p.491, 2018. ,
ZRANB2 localizes to supraspliceosomes and influences the alternative splicing of multiple genes in the transcriptome, Mol. Biol. Rep, vol.40, pp.5381-5395, 2013. ,
Genetic and physical interactions between factors involved in both cell cycle progression and pre-mRNA splicing in Saccharomyces cerevisiae, Genetics, vol.156, pp.1503-1517, 2000. ,
Mutations in genes of Saccharomyces cerevisiae encoding pre-mRNA splicing factors cause cell cycle arrest through activation of the spindle checkpoint, Nucleic Acids Res, vol.30, pp.4361-4370, 2002. ,
Silencing of p29 affects DNA damage responses with UV irradiation, Cancer Res, vol.66, pp.8484-8491, 2006. ,
Involvement of p29 in DNA damage responses and Fanconi anemia pathway, Carcinogenesis, vol.30, pp.1710-1716, 2009. ,
Disruption of murine mp29/Syf2/Ntc31 gene results in embryonic lethality with aberrant checkpoint response, PLoS One, vol.7, p.33538, 2012. ,
PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry, Mol. Cell, vol.53, pp.235-246, 2014. ,
Cdc5L interacts with ATR and is required for the S-phase cell-cycle checkpoint, EMBO Rep, vol.10, pp.1029-1035, 2009. ,
The PSO4 protein complex associates with replication protein a (RPA) and modulates the activation of ataxia telangiectasia-mutated and RAD3-related (ATR), J. Biol. Chem, vol.289, pp.6619-6626, 2014. ,
Replication stress response in cancer stem cells as a target for chemotherapy, Semin. Cancer Biol, vol.53, pp.31-41, 2018. ,
Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics, J. Natl. Cancer Inst, vol.102, pp.1637-1652, 2010. ,
Identification and functional analysis of Zranb2 as a novel Smad-binding protein that suppresses BMP signaling, J. Cell. Biochem, vol.113, pp.808-814, 2012. ,
ZRANB2 / SNHG20 / FOXK1 Axis regulates Vasculogenic mimicry formation in glioma, J. Exp. Clin. Cancer Res, vol.38, p.68, 2019. ,
Overexpression of SYF2 promotes cell proliferation and correlates with poor prognosis in human breast cancer, Oncotarget, vol.8, pp.88453-88463, 2017. ,
,
, Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer, J. Clin. Oncol, vol.24, pp.1839-1845
HNRNPM guides an alternative splicing program in response to inhibition of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells, Nucleic Acids Res, vol.45, pp.12270-12284, 2017. ,